Lyfstone
Abcoude
About Lyfstone
Lyfstone develops biomarkers. They provide products and solutions for calprotectin analysis in feces, plasma, and serum samples. They enable diagnostic insights including the assessment of IBD, rheumatic diseases, and distinguishing bacterial from viral infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Mar 2008)
- Website: lyfstone.com
- Phone: + 31 6531 61 102
Industries & Categories
Biopharma, Biotechnology, Sales
Social Profiles
Canonical: https://fsome.com/organization/lyfstone-660722 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.